Aardvark Therapeutics Statistics

Total Valuation

AARD has a market cap or net worth of $184.85 million. The enterprise value is $111.97 million.

Market Cap	184.85M
Enterprise Value	111.97M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

AARD has 21.70 million shares outstanding. The number of shares has increased by 0.90% in one year.

Current Share Class	21.70M
Shares Outstanding	21.70M
Shares Change (YoY)	+0.90%
Shares Change (QoQ)	+1.90%
Owned by Insiders (%)	14.49%
Owned by Institutions (%)	4.82%
Float	11.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.05, with a Debt / Equity ratio of 0.01.

Current Ratio	15.05
Quick Ratio	14.95
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.70% and return on invested capital (ROIC) is -34.67%.

Return on Equity (ROE)	-50.70%
Return on Assets (ROA)	-32.35%
Return on Invested Capital (ROIC)	-34.67%
Return on Capital Employed (ROCE)	-31.39%
Revenue Per Employee	n/a
Profits Per Employee	-$935,818
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.63
Average Volume (20 Days)	130,076

Short Selling Information

The latest short interest is 467,120, so 2.15% of the outstanding shares have been sold short.

Short Interest	467,120
Short Previous Month	332,071
Short % of Shares Out	2.15%
Short % of Float	4.13%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.79M
Pretax Income	-13.85M
Net Income	-20.59M
EBITDA	-22.77M
EBIT	-22.79M
Earnings Per Share (EPS)	-$5.15

Full Income Statement

Balance Sheet

The company has $73.66 million in cash and $779,000 in debt, giving a net cash position of $72.88 million or $3.36 per share.

Cash & Cash Equivalents	73.66M
Total Debt	779,000
Net Cash	72.88M
Net Cash Per Share	$3.36
Equity (Book Value)	72.11M
Book Value Per Share	-13.44
Working Capital	69.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.09 million and capital expenditures -$109,000, giving a free cash flow of -$18.20 million.

Operating Cash Flow	-18.09M
Capital Expenditures	-109,000
Free Cash Flow	-18.20M
FCF Per Share	-$0.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AARD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.90%
Shareholder Yield	-0.90%
Earnings Yield	-11.14%
FCF Yield	-9.84%

Analyst Forecast

The average price target for AARD is $31.50, which is 293.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$31.50
Price Target Difference	293.75%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2